News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
News|Videos|December 23, 2019

Overview of Cutaneous Squamous Cell Carcinoma Management

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Bone Marrow.

CAR-NK Shows Long-Term Response in Waldenström Non-Hodgkin Lymphoma

BySpencer Feldman
January 22nd 2026
The allogeneic CAR-T therapy aims to expand urgently needed options for children and adults with aggressive T-cell blood cancers: © stock.adobe.com.

FDA Grants Breakthrough Designation to Sofi-cel for Relapsed/Refractory T-Cell ALL/LBL

ByRyan Scott
January 22nd 2026
The FDA has granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare blood cancer: © stock.adobe.com.

FDA Orphan Drug Designation Granted to Zavabresib for Myelofibrosis

ByRyan Scott
January 22nd 2026
CURE spoke with advocate Karen Hoyt about liver cancer, liver disease, and liver health, highlighting silent risk, misconceptions and need for awareness.

A Liver Cancer Advocate Highlights Risk, Misconceptions and Awareness

ByRyan Scott
January 21st 2026
Image of man.

Pancreatic Cancer Treatment Options and Strategies for Patients

BySpencer Feldman
January 21st 2026
Advertisement
Advertisement

Trending on CURE

1

How A Cancer Vaccine and Keytruda Work to Treat Patients With Melanoma

2

Pancreatic Cancer Treatment Options and Strategies for Patients

3

How Ikebana Helped Me Navigate Life With Cancer

4

Cancer Vaccine Plus Keytruda Reduces Melanoma Recurrence or Death

5

A Liver Cancer Advocate Highlights Risk, Misconceptions and Awareness

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.